 Oxaliplatin (OX)-containing solutions obtained during patient treatment with Hyperthermic intraperitoneal chemotherapy (HIPEC) unexpectedly showed low cytotoxicity in an impedance-based ex vivo cytotoxicity cell assay.  OX cytotoxicity under HIPEC conditions could be enhanced by extending drug exposure to one hour by an impedance-based ex vivo cytotoxicity cell assay.  HIPEC failed to show survival benefits in the randomized controlled PRODIGE 7 trial and was questioned in the aftermath.  Clinically relevant OX concentrations applied in conjunction with hyperthermia (42 °C) for 30 minutes, as used either at our own medical center or according to the PRODIGE 7 trial, proved predominantly ineffective, when used according to HIPEC routines in an impedance-based in vitro cytotoxicity cell assay.  Respective findings were corroborated in two different cell lines and by two established end-point assays, showing that 50 % cell death could not be reached by the same HIPEC treatment with OX, in contrast to continuous drug exposure.  As potentially relevant factor, the thickness of the exposed cell layer was identified, requiring at least ~100 µm penetration depth for our model to indicate effectiveness.  Additionally, we show relevant cell shrinkage by two drug diluents used either at our own medical center or according to the PRODIGE 7 trial, potentially associated with fluid shifts out of the cell and impaired drug effects.  Our own as well as recent findings by Ubink et al. (Br J Surg. 2019. doi: 10.1002/bjs.11206) support the notion that lacking effectiveness of OX HIPEC may explain the negative PRODIGE 7 trial results.
Abstract
Cytotoxicity of oxaliplatin-containing solutions (OCS), sampled during patient treatment with hyperthermic intraperitoneal chemotherapy (HIPEC), was assessed by well-established continuous impedance-based real-time cell analysis (RTCA) ex vivo. HIPEC treatment was replicated by exposing OAW-42 cancer cells to OCS for 30 or 60 minutes at 42 °C. In contrast to previous observations with continuous exposure, where cytotoxicity was proven, identical OCS obtained during HIPEC did not induce cell death reproducibly and showed strongly attenuated effects after only 30 minutes of application. Based on these unexpected findings, spike-ins of oxaliplatin (OX) into peritoneal dialysis solution (PDS) or dextrose 5 % in water (D5W) were used to replicate HIPEC conditions, as used in either our own protocols or the recently presented randomized controlled PRODIGE 7 trial, where OX HIPEC for 30 minutes failed to produce survival benefits in colorectal carcinoma patients. With OX-spiked into D5W or PDS at identical concentrations as used for PRODIGE 7 or conforming with own HIPEC protocols, we did not observe the expectable cytotoxic effects in RTCA, after replicating OX HIPEC for 30 minutes. These results were corroborated for both solvents at relevant drug concentrations by classical end-point assays for cytotoxicity in two cancer cell lines. Further results suggest that penetration depth, drug dosage, exposure time and drug solvents may constitute critical factors for HIPEC effectiveness. Accordingly, we witnessed substantial cell shrinkage with both PDS and D5W, potentially contributing to reduced drug effects. Based on these results, intensified pharmacological research seems warranted to establish effective HIPEC protocols.
Introduction
Hyperthermic intraperitoneal chemotherapy (HIPEC) was introduced about four decades ago (1, 2) and it is meanwhile an established treatment option for peritoneal metastasis (PM), in combination with cytoreductive surgery (CRS). This approach of complete macroscopic surgical tumor removal combined with immediate intraoperative heated abdominal chemotherapy lavage was adopted worldwide and is currently most common in the treatment of PM from colorectal (CRC) and ovarian cancers (OvCa) (3) . In contrast to CRS, where attempts of standardization do exist (4) and a learning curve for surgical improvement is well-established (5, 6) , HIPEC treatment remains very heterogeneous (3, 7) . A theoretical basis providing a rationale for adding HIPEC to CRS is the pharmacokinetic advantage of exposing malignant cells directly to high drug concentrations (8) as well as a compartmental effect called peritonealplasma barrier (9) , which presumes that peritoneal malignancies are only insufficiently reached by intravenous (i.v.)
chemotherapies.
Historically, PM has been regarded as a palliative disease stage with very limited survival prospects. The first randomized controlled clinical trial (RCT) with CRS + HIPEC vs. systemic chemotherapy showed a significantly improved median overall survival (OS) that increased from 12.6 months to 22.3 months in the CRS + HIPEC group in CRC (10) . In this trial by Verwaal et al., HIPEC treatment involved mitomycin c (MMC) exposure for 90 minutes and the treatment was associated with long-term benefit for some selected patients (11) .
Among the most frequently used drugs for PM in CRC is further oxaliplatin (OX) (12 Fig. 2 as well as Suppl. Fig. 1-14 .
Indeed, there were striking differences between different samples (i.e. OCS ≙ Physioneal peritoneal dialysis solution containing OX at 300 mg/m² body surface area; resulting in a calculated mean concentration of 93.7 µg/ml, ranging from 75.0-108.9 µg/ml (16)) obtained during HIPEC. Some OCS showed no cytotoxic effects in OAW-42 cells after 30 minutes exposure at 42 °C ( Fig. 2a) , which could be rescued by prolonged exposure in some cases ( Fig. 2b) . OCS from different patients showed effects already after 30 minutes exposure instead ( Fig. 2c) . Again, in this latter case cytotoxic effects were boosted by longer exposure to OCS (Fig. 2d) HIPEC showed a tendency to stronger effects and longer exposure proved more effective for reaching LC 50 values ( Fig. 2e) , procedure; (13, 14) ) as well as based on data from own HIPEC conduct (~90 µg/ml ≙ 227 µM) (16) . This dose range is also in line with previous published HIPEC in vitro models (17) .
In order to recreate the HIPEC setting, cells were exposed to OCS for 30 minutes at Using this cell culture model, we did not observe any treatment induced cell death induced when diluting OX in D5W up to a concentration of 230 µg/ml during three days of follow-up ( Fig. 3a) corresponding to the dosage used in the PRODIGE 7 trial) was effective in inducing cell death (Fig. 3b) , whereas effects stayed far behind of continuous exposure of OX spiked into medium ( Fig. 3c) In the CTB assay both the OAW-42 and the HT29 cell lines showed no reduction of mean cell viability below 50 % (LC 50 ) three days after treatment, in none of the assessed conditions (Fig. 4a) . The robustness of these findings was confirmed by reproducing respective results with the SRB assay.
Repeating experiments under identical conditions with OX spiked into PDS failed again to induce LC 50 at three days following treatment for all tested conditions (Fig. 4b) .
This was also evidenced for OX spiked into
Ringer´s lactate solution (RL) (Suppl. Fig.   19 ), even though drug effects seemed slightly more pronounced than those observed with OX spiked into D5W and PDS. In contrast, when OX was spiked into culture medium (to allow for extended cultivation) and remained with the cells, both cell lines (OAW-42 and HT29) showed clearly enhanced induction of cell death. Cell viability reproducibly decreased to <50 % (LC 50 ) within three days, when exposed to drug concentrations relevant for HIPEC (≥ 90 µg/ml ≙ 227 µM) with both assays and cell lines (Fig. 4c) . Platinum-sensitive OAW-42 cells and the colon carcinoma cell line HT29 were seeded at a density of 3.15 x 10 5 cells per well (in a 24-well plate) and incubated for 30 minutes at 42 °C with the specified amounts of OX spiked either into dextrose 5 % in water (D5W) (a), or into PDS (b). Further, cells were incubated continuously with the specified amounts of OX spiked into culture medium (MEM) to allow for continuous drug exposure and heated likewise initially (i.e. 30 minutes incubation at 42 °C followed by 72 hours at 37 °C) (c). After OX exposure, cells were washed and subsequently cultured in serum supplemented medium for another three days or remained with drugs in culture medium (MEM). Afterwards, a fluorometric resazurin-based (CellTiter-Blue ® , CTB) (left graph) and a sulforhodamine B (SRB) assay (right graph) was used to determine cell viability. Cells were normalized to cells treated identically with D5W/ PDS/ MEM only (viability ctrl.). (+ ctrl.): Triton. Graphs show mean ± SD from three independent experiments each performed in triplicates. The LC 50 threshold is marked with a black line.
Short-term exposure to drug diluents used in HIPEC for 30/ 60 minutes causes significant cell shrinkage in OAW-42 cells
Although high sugar containing aqueous solutions such as D5W and PDS are often used for OX dilution in HIPEC (7), this practice has been connected with frequent adverse events including post-operative hyperglycemia and/ or electrolyte disturbances (25) and was questioned based on pharmacological grounds (26) .
Nevertheless, since both D5W and PDS are hypertonic solutions, we assumed they may affect directly exposed OAW-42 cells based on their physiological properties. To this end, we exposed cells to D5W and PDS under conditions comparable to HIPEC (42 °C) and measured cellular appearance by flow cytometry. We found that 30 minutes exposure suffices to cause significant cell shrinkage with both D5W and PDS, compared to untreated cells (Fig. 5a) , which is further enhanced after 60 minutes (Fig.   5b ). This substantial decrease in cell size as proven by flow cytometry may be explainable by a relevant fluid shift to the extracellular space. OX stability in aqueous solutions is explained by concentration effects and has been determined at no less than three years in D5W, forming association complexes at high concentrations that may affect uptake and molecular drug mechanisms (35) . Its physicochemical stability in combination with D5W at concentrations >200 µg/ml (≙ ~500 µM) may further contribute to chemical inertness (36) .
In this context, we might also challenge the notion of OX inefficiency in chloride containing solutions (16, 26) , as these form (instable) intermediates with OX but retain their required cytotoxic properties (37) . OX derived monochloro-and dichlorocompounds have even been suggested to exert enhanced cytotoxicity (26) . Dextrosecontaining HIPEC vehicles instead may cause hyperglycemia (38) and electrolyte disturbances, which may influence postoperative morbidity and mortality (26) and have effects such as fluid shifts that may thwart the treatment.
Regardless, we assume the most important factor to be considered is drug penetration into cell layers, which is the best explanation for the RTCA findings and the enhanced drug effects after prolonged incubation even at substantially lower dosage. It should be considered that OX cytotoxicity is wellestablished for the used cell lines at a small fraction of the concentrations employed here (18, 24) . Since we used cell culture without substantial intercellular matrix or surrounding tissue, this may even become more relevant in vivo as already supposed in the past (8) .
Conclusion
Our results and previous work underscore the need for basic pharmacological research in HIPEC enabling to discern relevant factors in a complex multifaceted treatment. 
Materials and Methods

Patient materials
Studies on patient materials were approved by the institutional review board at Tübingen University. All patients gave their written informed consent before study inclusion.
Patient characteristics can be assessed elsewhere (16) . Drug solvent circulated through the abdomen of patients was collected prior to addition of OX (0 min) and 5, 10, 15, 20, 25 , and 30 minutes after starting the HIPEC procedure with OX. For
Pat. 8 and 9, samples were only obtained in 10-minute intervals. Samples were stored at -80 °C until usage. Cellular debris and other impurities were cleared by centrifugation (five minutes at 13,000 x g) before analysis.
Impedance-based real-time cell analysis (RTCA)
Materials and methods were used as established before (16), with slight modifications.
As described previously, platinum-sensitive
OAW-42 cells (European Collection of
Authenticated Cell Cultures, Salisbury, UK)
were grown under appropriate conditions, seeded and used as a model system to monitor cytotoxicity of OX in real time (16) .
In brief, cells were grown in culture medium 
CellTiter-Blue (CTB) Cell Viability Assay
To estimate effects on cell viability, 
Sulforhodamine B (SRB) Cytotoxicity Assay
OAW-42 and HT29 cells were seeded in 24- 
